[ (18) F]FDG PET/CT Studies in Transgenic Hualpha-Syn (A53T) Parkinson's Disease Mouse Model of α-Synucleinopathy.
[ (18) F]FDG PET/CT Studies in Transgenic Hualpha-Syn (A53T) Parkinson's Disease Mouse Model of α-Synucleinopathy.
复制标题
DOI:
10.3389/fnins.2021.676257
复制
发表时间:
2021
影响因子:
4.3
通讯作者:
Mukherjee J
中科院分区:
文献类型:
--
作者:
Mondal R;Campoy AT;Liang C;Mukherjee J
Transgenic mice line M83 that express the A53T mutant α–synuclein protein at six times the level of endogenous mice α–synuclein are a model of α-synucleinopathy found in Parkinson’s disease (PD). This Hualpha-Syn (A53T) PD model is useful in assessing non-motor deficits at earlier stages of onset of PD. We report findings on metabolic changes using [18F]FDG PET/CT in the Hualpha-Syn (A53T) PD mouse model in comparison to non-carrier mice. Whole-body PET/CT imaging of male and female mice were carried out 2 h after [18F]FDG ip administration under 3% isoflurane anesthesia. Brain images were analyzed with PET images coregistered to a mouse brain MRI template. Hualpha-Syn (A53T) mice had significantly lower [18F]FDG uptake in several brain regions compared to the no-carrier mice. Significant hind limb muscle and lower spinal cord [18F]FDG hypometabolism at 9 months of age in A53T PD mice was also indicative of neurodegenerative disease, with a progressive motoric dysfunction leading to death. Significant decrease (up to 30%) in [18F]FDG uptake were observed in 9-month old male and female Hualpha-Syn (A53) mice. This is consistent with the cortical hypometabolism in PD patients. Hualpha-Syn (A53) mice may thus be a suitable model for studies related to PD α-synucleinopathy for the discovery of new biomarkers.
登录
查看更多内容
影响因子:
3.5
作者:
Constantinescu CC;Mukherjee J
通讯作者:
Mukherjee J
影响因子:
16.2
作者:
Giasson, BI;Duda, JE;Lee, VMY
通讯作者:
Lee, VMY
影响因子:
3.7
作者:
Paumier KL;Sukoff Rizzo SJ;Berger Z;Chen Y;Gonzales C;Kaftan E;Li L;Lotarski S;Monaghan M;Shen W;Stolyar P;Vasilyev D;Zaleska M;D Hirst W;Dunlop J
通讯作者:
Dunlop J
影响因子:
6.3
作者:
Ma, Yilong;Tang, Chengke;Eidelberg, David
通讯作者:
Eidelberg, David
DOI:
10.1038/npjparkd.2016.1
发表时间:
2016
期刊:
NPJ Parkinson's disease
影响因子:
--
作者:
Perez-Lloret S;Barrantes FJ
通讯作者:
Barrantes FJ